Adrenal Steroids 2 Flashcards

1
Q

Betamethasone - MoA

A

Promotes fetal lung maturation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Betamethasone - Clinical use

A

Prevent RDS in premature infants by leading to lung maturation, psoriasis, seborrheic/atopic dermatitis, neurodermatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Betamethasone - Special considerations

A

Can enter placenta, used systemically and topically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Budesonide - Clinical use

A

Ulcerative colitis

Asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ciclesonide - Clinical use

A

Hay fever/ allergic rhinitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Beclomethasone, Flunisolide and Mometasone furoate - Clinical use

A

Extremely good for asthma, allergic rhinitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Topical steroids

A
Loteprednol
Difluprednate
Desonide 
Hydrocortisone
Dexamethasone
Fluticasone
Triamcinolone
Desoximethasone
Fluocinonide 
Clobetasol
Betamethasone
Dipropionate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Low-potensy topical steroids

A

Desonide
Hydrocortisone
Dexamethasone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Medium-potensy topical steroids

A

Fluticasone

Triamcinolone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

High-potency topical steroids

A

Desoximethasone

Fluocinonide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Very-high-potency topical steroids

A

Clobetasol
Betamethasone
Dipropionate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Topical corticosteroids - Special consideration

A

Ointment: dry, cracked, scaly or hardened skin.

Lotions and gels: hairy areas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ophthalmis cortisol preparations

A

Loteprednol

Difluprednate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Loteprednol - Clinical use

A

With tobramycin for corneal inflammation and keratitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Difluprednate - Clinical use

A

Pain and inflammation associated with ocular surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Desonide,
Hydrocortisone,
Dexamethasone - Clinical use

Fluticasone - Clinical use

A

Redness, swelling, itching in various skin conditions (Atopic dermatitis, seborrheic dermatitis, contact dermatitis, and psoriasis)

Asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Low potency steroids used in what kind of areas?

A

Areas with thinner skin and intertriginous areas where skin is folded or overlapped.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Low to medium potency used in what kind of areas?

A

ears, trunk, arms, legs and scalp.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Medium to very high potency are used in what kind of areas?

A

thicker skin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Mineralocorticoids - MoA

A

Na+ reabsorption coupled (loosely) with K+ & H+ excretion. Binds to mineralocorticoid receptors in cytoplasm causing increased expression of Na/K-ATPase & epithelial sodium channels. (Receptors have same affinity for cortisol, but in kidney cortisol is converted to cortisone with lower affinity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Mineralocorticoids - Adverse Effects

A

Hypokalemia, metabolic alkalosis, Increased plasma volume, hypertension

22
Q

Fludrocortisone - MoA

A

Both glucocorticoid and mineralocorticoid actions

Potent salt retaining activity

23
Q

Fludrocortisone - Clinical use

A

Primary adrenal insufficiency (Addison`s disease)
Preferred in replacement therapy in adenectomy
CAH in combo with hydrocortisone.

24
Q

Fludrocortisone - Special considerations

A

Also glucocorticoid activity, but 20 times more potent salt-retaining activity

Only oral adm

25
Adrenal androgens
DHEA (Dehydroepiandrosterone)
26
DHEA - Clinical use
USED IN ALTERNATIVE MEDICINE Studies indicate: protective for DM, immune disorders, cancer, weight gain, increased muscle mass and sexual function, and prolong life.
27
DHEA - Contraindication and Special consideration
Prostate cancer (because it is a weak androgen) Extremely weak androgen, partly converted to testosterone.
28
DHEA - Adverse effects
Mild acne, seborrhea, and facial hair growth
29
Corticosteroid receptor antagonists
Spironolactone Eplerenone Mifepristone
30
Spironolactone - MoA
Competitive inhibition of mineralocorticoids receptors in the kidney
31
Spironolactone - Clinical use
Used as potassium-sparing diuretic, Primary hyperaldosteronism (DOC)– diagnostic & therapeutic, Secondary hyperaldosteronism (with heart failure, Bartter syndrome) Hirsutism in women
32
Spironolactone - Special consideration
Reduce mortality in heart failure | Potassium-sparing diuretic.
33
Spironolactone - Adverse Effect
Hyperkalemia, cardiac arrhythmias, menstrual abnormalities, gynecomastia, sedation, headache, GI disturbances, skin rashes
34
Eplerenone - Clinical use
Hypertension
35
Eplerenone - Special consideration
Reduce mortality in heart failure | No effect on androgen receptors
36
Eplerenone - Adverse effects
Hyperkalemia (usually mild)
37
Mifepristone - MoA
It antagonizes both progesterone and glucocorticoid receptors
38
Mifepristone - Clinical use
Cushing’s syndrome (esp. hyperglycemia in patients with cushing syndrome)
39
Mifepristone - Special consideration
Strong antiprogestin activity (first intended to be contraceptive)
40
Corticosteroid synthesis inhibitors
Ketoconazole Fluconazole Aminoglutethimide Metyrapone
41
Ketoconazole and Fluconazole - MoA
Inhibits steroid production by inhibiting 11β-hydroxylase (fungal cytochrome P450 enzyme)
42
Ketoconazole and Fluconazole - Clinical use
Cushing syndrome | Adrenal carcinoma, hirsutism, breast & prostate cancer.
43
Ketoconazole and Fluconazole - Adverse effects
Hepatotoxicity | Gynecomastia
44
Aminoglutethimide - MoA
Blocks conversion of cholesterol to pregnenolone & inhibits synthesis of all hormonally active steroids
45
Aminoglutethimide - Clinical use
- Reduce estrogen production in pt with breast cancer (in combo with dexamethasone and hydrocortisone) - Reduce steroid secretion in pt with Cushing`s syndrome due to adrenocortical cancer who do not respond to mitotane (in combo with metyrapone or ketoconazole)
46
Aminoglutethimide - Adverse effects and interactions
High doses: Lethargy and skin rash | Interactions: increased Metabolism of dexamethasone
47
Metyrapone - MoA
Inhibits glucocorticoid synthesis by selectively inhibiting 11β-hydroxylation, shifts production to adrenal androgens
48
Metyrapone - Clinical use
Diagnostic test of adrenal function Pregnant women with Cushing syndrome (ONLY drug for this). Cushing syndrome in pt whose condition is refractory to other treatments and who are not candidates for surgery Preparation for surgery
49
Metyrapone - Special consideration
Not normally used for Cushing syndrome (only choice for pregnancy. Also if other drugs failed and not candidate for surgery)
50
Metyrapone - Adverse effects
Transient dizziness and GI disturbances Salt and water retention Hirsutism